journal article·2025-12

Hyaluronic acid oligosaccharides promote micro-vessel growth and regenerative ossification in biomimetic calvarial bone scaffolds

Weibin Jia, Liling Liu, Min Li, Qianqian Shen, Guozhen Qi, Ruipiao Zhou, Mengran Yang, Fengshan Wang, Zonggang Chen

Acta Biomaterialia· Volume 208
Publisher page

Abstract

Bone regeneration requires well-orchestrated cellular and molecular interactions, particularly vascularization and osteoprogenitor migration and differentiation. Calvarial bone healing is featured by a temporal uncoupling of angiogenesis and osteogenesis: (ⅰ) osteoprogenitors derived from periosteum differentiate into osteoblasts at the injury site, followed by (ⅱ) osteogenic cells invade into the vascularized lesion. Promoting intra-defect micro-vessel growth may enhance osteogenic migration and accelerate ossification during calvarial bone repair. In this study, hyaluronic acid oligosaccharides (oHAs) were incorporated into tissue scaffolds, serving as the stimulators of micro-vessel formation and rising blood perfusion for calvarial bone repair. First, oHAs were tethered in chitosan (oHAs-CTS) and mineralized collagen (oHAs-mHAP) and then fabricated into porous bone scaffolds. The scaffolds' morphology, physicochemical/mechanical properties and degradation behaviors were systematically characterized. After 10 weeks in vivo implantation, oHAs-functionalized scaffolds achieved a 5.1-fold defect closure over blank control and a 2.6-fold over non-oHAs-functionalized groups. This enhancement of regenerative ossification was mechanistically linked to robust micro-vessel invasion within the scaffolds, as evidenced by quantitative analysis of vascular markers using molecular biology methods. While the mechanism underlying angiogenesis-osteogenesis coupling remains incompletely understood, our findings reveal that oHAs-functionalized scaffolds promote micro-vessel invasion and regenerative ossification during calvarial bone repair. STATEMENT OF SIGNIFICANCE: Low-molecular-weight hyaluronic acid oligosaccharides (oHAs), functioning as damage-associated molecular patterns (DAMPs), demonstrate paradoxical pro-angiogenic bioactivity through modulating endothelial cell behaviors, including proliferation, migration, and microvascular morphogenesis. Capitalizing on this mechanism, we engineered oHA-functionalized biomimetic bone scaffolds that significantly enhanced neovascularization in calvarial defect models. This strategy concurrently addresses two critical challenges: the inherent avascularity of engineered bone grafts and the impaired self-repair capacity of calvarial defects by promoting intra-construct microvascularization.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Osteoarthritis Treatment and Mechanisms · Proteoglycans and glycosaminoglycans research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. Research advances of nanomaterials for the acceleration of fracture healing
2. Angiogenesis is uncoupled from osteogenesis during calvarial bone regeneration10.1038/s41467-024-48579-5 ↗
3. Bone fracture acute phase response—a unifying theory of fracture repair: clinical and scientific implications10.1007/s12018-018-9256-x ↗
4. Engineering pre-vascularized bone-like tissue from human mesenchymal stem cells through simulating endochondral ossification10.1016/j.biomaterials.2022.121451 ↗
5. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone10.1038/nature13145 ↗
6. The osteo-angiogenic signaling crosstalk for bone regeneration: harmony out of complexity10.1016/j.copbio.2022.102750 ↗
7. The early fracture hematoma and its potential role in fracture healing10.1089/ten.teb.2009.0687 ↗
8. Vascular tissue engineering: progress, challenges, and clinical promise10.1016/j.stem.2018.02.009 ↗
9. Robust coupling of angiogenesis and osteogenesis by VEGF-decorated matrices for bone regeneration10.1016/j.actbio.2022.07.014 ↗
10. Neovascularization of engineered tissues for clinical translation: where we are, where we should be?10.1063/5.0044027 ↗
11. Hyaluronic acid oligosaccharide-modified collagen nanofibers as vascular tissue-engineered scaffold for promoting endothelial cell proliferation10.1016/j.carbpol.2019.115106 ↗
12. Extracellular matrix-derived materials for tissue engineering and regenerative medicine: a journey from isolation to characterization and application
13. Hyaluronan and its receptors as regulatory molecules of the endothelial interface10.1369/0022155420954296 ↗
14. Advances in hyaluronic acid: bioactivity, complexed biomaterials and biological application: a review10.1016/j.asjsur.2024.08.100 ↗
15. Modified hyaluronic acid based materials for biomedical applications10.1016/j.ijbiomac.2018.10.049 ↗
16. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention10.1038/s41392-022-00955-7 ↗
17. Decorating delivery vehicles using hyaluronic acid oligosaccharides enables active targeting toward cancer and minimizes adverse effect of chemotherapeutics10.1002/adhm.202402158 ↗
18. Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer10.3389/fimmu.2015.00201 ↗
19. Hyaluronic acid promotes angiogenesis by inducing RHAMM-tgfβ receptor interaction via CD44-pkcδ10.1007/s10059-012-2294-1 ↗
20. Citrate stabilizes hydroxylapatite precursors: implications for bone mineralization10.1021/acsbiomaterials.1c00196 ↗
21. Hydroxyapatite: a journey from biomaterials to advanced functional materials10.1016/j.cis.2023.103013 ↗
22. Hyaluronic acid oligosaccharides modified mineralized collagen and chitosan with enhanced osteoinductive properties for bone tissue engineering10.1016/j.carbpol.2021.117780 ↗
23. Fabrication and comprehensive characterization of biomimetic extracellular matrix electrospun scaffold for vascular tissue engineering applications10.1007/s10853-019-03667-6 ↗
24. Hydration of polymeric components of cartilage — an infrared spectroscopic study on hyaluronic acid and chondroitin sulfate10.1016/S0141-8130(00)00161-6 ↗
25. Developing fibrin-based biomaterials/scaffolds in tissue engineering
26. Recent advances in biodegradable polymers for sustainable applications10.1038/s41529-022-00277-7 ↗
27. Poly(lactic-co-glycolic acid)-based composite bone-substitute materials
28. Effect of chitosan reinforcement on properties of hydroxyapatite/silk fibroin composite for biomedical application10.1016/j.physe.2021.114734 ↗
29. In Vitro–In vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia10.1007/s11095-010-0152-4 ↗
30. High-strength cellular ceramic composites with 3D microarchitecture10.1073/pnas.1315147111 ↗
31. Design and fabrication of a biomimetic vascular scaffold promoting in situ endothelialization and tunica Media regeneration10.1021/acsabm.8b00269 ↗
32. Scaffolds for bone-tissue engineering10.1016/j.matt.2022.06.003 ↗
33. Vascularization and angiogenesis in tissue engineering: beyond creating static networks10.1016/j.tibtech.2016.03.002 ↗
34. Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer10.3389/fimmu.2015.00201 ↗
35. Hyaluronic acid receptor-mediated nanomedicines and targeted therapy10.1002/smtd.202400513 ↗
36. Hyaluronan: molecular size-dependent signaling and biological functions in inflammation and cancer10.1111/febs.14777 ↗
37. Hyaluronic acid promotes angiogenesis by inducing RHAMM-tgfβ receptor interaction via CD44-pkcδ10.1007/s10059-012-2294-1 ↗
38. Insights into the mechanism of vascular endothelial cells on bone biology10.1042/BSR20203258 ↗
39. The roles of vascular endothelial growth factor in bone repair and regeneration10.1016/j.bone.2016.06.013 ↗